    |
XVI REGIONAL |
|
Words of Welcome Message from the President Key Information Organisation - Committees Scientific Programme saturday - sunday - monday - tuesday - Abstracts & Posters Instructions Registration Information General Information Excursion Programme Social Programme Exhibitions Hotel Accomodation Acknowledgements Official Carrier More about the ISBT |
 |
|
November 12 - 15, 2005 Bangkok Convention Centre Thailand - Bangkok www.isbt-web.org/bangkok Second Announcement |
Programme - at - a - glance
TIME |
Saturday, November 12 |
|
Auditorium A2 |
Auditorium B2 |
|
| 07.30-17.00 | Registration | |
| 08.30-09.10 |
EP 1 Immunology & Immunohematology |
|
| 09.10-09.50 |
EP 2 Red Cell Blood Groups |
|
| 09.50-10.30 |
EP 3 HLA |
|
| 10.30-10.50 | Coffee break | |
| 10.50-11.30 |
EP 4 Hemostasis |
|
| 11.30-12.10 |
EP 5 Marketing in Donor Recruitment |
|
| 12.10-13.40 | Lunch break | |
| Satelite Symposium Baxter | ||
| 13.40-14.10 |
EP 6 TTD |
|
| 14.10-14.40 |
EP 7 NAT |
|
| 14.40-15.00 | Tea break | |
| 15.00-15.30 |
EP 8 EQA |
|
| 18.00-19.00 | Opening Ceremony | |
| 19.00-21.00 | Welcome Reception in the Exhibition Area | |
|
|
|
|
Auditorium A2 |
Auditorium B2 |
|
| 08.00-17.00 | Registration | |
| 08.30-10.00 | Plenary Lecture 1 | |
| 10.00-10.30 | Coffee break | |
| 10.30-12.00 | Plenary Lecture 2 | |
| 12.00-13.30 | Lunch break Visit to the exhibition and posters | |
| Satelite Symposium Chiron Asia Pacific | Sat. Symposium Bio Rad Laboratories Ltd. | |
| 13.30-15.00 |
PS 1 What is new in Blood Components |
PS 2 Risk Management in Blood Transfusion |
| 15.00-15.30 | Tea Break | |
| 15.30-17.00 |
PS 3 External Quality Assessment Scheme |
PS 4 New Approaches in Controlling TTDs |
| 17.00-18.30 | Satelite Symposium Pall LifeScience | |
|
|
|
|
Auditorium A2 |
Auditorium B2 |
|
| 08.00-17.00 | Registration | |
| 08.30-10.00 | Plenary Lecture 3 | |
| 10.00-10.30 | Coffee break | |
| 10.30-12.00 |
PS 5 Quality Management System |
PS 6 Stem Cell Transplant |
| 12.00-13.30 | Lunch break Visit to the exhibition and posters | |
| Satelite Symposium Abbott | Satelite Symposium Roche | |
| 13.30-15.00 |
PS 7 Practical Approach to TTI Testing |
PS 8 Bloodless Medicine |
| 15.00-15.30 | Tea Break | |
| 15.30-17.00 |
PS 9 The Art of Donor Recruitment |
PS 10 Blood Transfusion Immunology |
| XX.XX-XX.XX | Gala Dinner | |
|
|
|
|
Auditorium A2 |
Auditorium B2 |
|
| 08.00-17.00 | Registration | |
| 08.30-10.00 | PS 11 Technology and Blood Transfusion |
PS 12 Disaster Management |
| 10.00-10.30 | Coffee break | |
| 10.30-12.00 | PS 13 Risk Management of Donor |
PS 14 Component Support in Special Clinical Setting |
| 12.00-13.30 | Lunch break Visit to the exhibition and posters | |
| Satelite Symposium Bio-One | ||
| 13.30-15.00 | Plenary Lecture 4 | |
| 15.00-15.30 | Closing Ceremony | |
|
|
EDUCATIONAL DAYSaturday, November 12 |
|
08.30 – 10.30 Auditorium B2 |
|
| SESSION 1 | |
| 08:30 – 09:10 | |
| 1ED-01-01 IMMUNOLOGY & IMMUNOHEMATOLOGY | |
| P. Hollland (Delta Blood Bank, Elk Grove, Ca, USA) | |
| 09:10 – 09:50 | |
| 1ED-01-02 RED CELL BLOOD GROUPS | |
| C.M. Westhoff (American Red Cross and the University of Pennsylvania, Philadelphia, USA) | |
| 09:50 – 10.30 | |
| 1ED-01-03 HLA | |
| J. McCluskey (University of Melbourne, Melbourne, Australia) |
|
| 10:30 – 10:50 | |
| COFFEE BREAK |
|
10:50 – 12:10 Auditorium B2 |
|
| SESSION 2 | |
| 10:50 – 11.30 | |
| 1ED-02-01 HAEMOSTASIS | |
| Y. Ayob (National Blood Centre, Kuala Lumpur, Malaysia) | |
| 11:30 – 12:10 | |
| 1ED-02-02 MARKETING IN DONOR RECRUITMENT | |
| P.F.W. Strengers (Sanquin, Amsterdam, The Netherlands) |
|
| 12:10 – 13:40 | |
| LUNCH BREAK | |
|
|
12.10-13.40 Satellite Symposium organised by Baxter Auditorium B2 |
|
| CURRENT AND FUTURE VALUE OF AMICUS SINGLE DONOR PLATELETS STORED IN ADDITIVE SOLUTION | |
| Chr. Stebler Gysi (Blood Transfusion Service, Basel, Switzerland) | |
|
|
|
13:40 – 14:40
Auditorium B2
|
|
| SESSION 3 | |
| 13:40 – 14:10 | |
| 1ED-03-01 TTD | |
| S. Wendel (Hospital Sirio Libanês Blood Bank, Sao Paulo, Brazil) | |
| 14:10 – 14:40 | |
| 1ED-03-02 NUCLEIC ACID TESTING: NAT AND BLOOD SAFETY | |
| J.P. Allain (University of Cambridge, Cambridge, United Kingdom) |
|
| 14:40 – 15:00 | |
| TEA BREAK |
|
|
15:00 – 15:30
Auditorium B2
|
|
| SESSION 4 | |
| 15:00 – 15:30 | |
| 1ED-04-01 EXTERNAL QUALITY ASSESSMENT; ITS PLACE IN THE QUALITY ASSURANCE OF BLOOD SERVICE LABORATORIES | |
| E. Dax, S. Walker, D. Jardine (National Serology Reference Laboratory,
Fitzroy, Australia) |
|
|
18:00 – 19:00
Auditorium B2
|
|
| OPENING CEREMONY |
|
|
19:00 – 21:00
Exhibition Area
|
|
| WELCOME RECEPTION |
|
|
|
PLENARY LECTURESSunday, November 13 |
|
| 08:30 – 10:00 Auditorium A2 | |
| PLENARY LECTURES 1: Present and Future Trends of Safe Blood Transfusion | |
| Chairs: P.V. Holland, P. Isarangkura | |
| 08:30 – 09:15 | |
| 2PL-01-01 PRESENT AND FUTURE TRENDS OF SAFE BLOOD TRANSFUSION INFECTIOUS SCREENING | |
| S. Wendel (Hospital Sirio Libanês Blood Bank, Sao Paulo, Brazil) | |
| 09:15 – 10:00 | |
| 2PL-01-02 ENZYME-CONVERTED RED BLOOD CELLS FOR ABO-UNIVERSAL TRANSFUSION | |
| M. Olsson (University Hospital, Lund, Sweden) |
|
| 10:00 – 10:30 | |
| COFFEE BREAK |
|
|
10:30 – 12:00
Auditorium A2
|
|
| PLENARY LECTURES 2: Red Cell Antigens | |
| Chairs: S. Wendel, R. O'Charoen | |
| 10:30 – 11:15 | |
| 2PL-02-01 NEW HORIZONS IN BLOOD GROUP TYPING | |
| C.M. Westhoff (American Red Cross and the University of Pennsylvania, Philadelphia, USA) | |
| 11:15 – 12:00 | |
| 2PL-02-02 RARE BLOOD DONOR | |
| Y. Tani (Japanese Red Cross Osaka Blood Center, Osaka, Japan) |
|
| 12:00 – 13:30 | |
| LUNCH BREAK, VISIT TO THE EXHIBITION AND POSTERS |
|
SATELLITE SYMPOSIUM |
|
|
12.00 – 13.30
Satellite Symposium organised by Chiron
Auditorium A2
|
|
| Partnership in Blood Safety | |
| EFFORTS TO ENSURE BLOOD SAFETY | |
| W. Heaton (Chiron Corporation, Emeryville, USA) | |
| ROAD TO NAT TESTING – MEDICAL JUSTIFICATION AND GOVERNMENT POLICY | |
| Y. Ayob (Kuala Lumpur, Malaysia) | |
| TIGRIS EXPERIENCE | |
| Speaker to be announced | |
|
|
|
12.00 – 13.30
Satellite Symposium organised by Bio Rad Laboratories Ltd.
Auditorium B2
|
|
| Place of HCV and HIV Combo Simultaneous Antigen and Antibody Detection in Blood Bank: A credible alternative to NAT ? | |
| ADVANTAGES OF HIV COMBO ASSAYS VERSUS HIV ANTIBODY ASSAYS | |
| L. Thoai Duong (Laboratoire L.C.L. France) | |
| COMBINATION HCV ANTIGEN AND ANTIBODY IMMUNOASSAY AS A NEW TOOL FOR EARLY DIAGNOSIS OF INFECTION | |
| F. Ansaldi (University of Genoa, Genoa, Italy) | |
| PLACE OF COMBINED HCV ANTIGEN AND ANTIBODY ASSAY IN THE SCREENING OF BLOOD DONATIONS | |
| S. Laperche (Institut National de la Transfusion Sanguine, Paris, France) | |
| COST-EFFECTIVENESS OF HCV AG/AB COMBO DETECTION VERSUS HCV NAT FOR SCREENING BLOOD DONATIONS | |
| R. Van Hulst (University of Groningen, Groningen, The Netherlands) | |
|
|
|
13:30 – 15:00
Auditorium A2
|
|
| PARALLEL SESSION 1: What is new in Blood Components | |
| Chairs: M. Popovsky, C.K. Lin | |
| 13:30 – 13:50 | |
| 2PS-01-01 CLINICAL BENEFITS OF PLASMA-REDUCED BLOOD COMPONENTS | |
| M.A. Popovsky (Haemonetics Corporation, Braintree, Ma, USA) | |
| 13:50 – 14:10 | |
| 2PS-01-02 ROUTINE BACTERIAL SURVEILLANCE OF PLATELET CONCENTRATES | |
| C.K. Lin (Hong Kong RC Blood Transfusion Service, Hong Kong, China) | |
| 14:10 – 14:20 | |
| 2PS-01-03 COMPARISON OF PLATELETPHERESIS ON THREE CELL SEPARATORS BASED ON THE CONTINUOUS FLOW CENTRIFUGATION PRINCIPLE | |
| A. Tendulkar, S. Chaaya, S. Rajadhyaksha (Tata Memorial Hospital, Mumbai, India) | |
| 14:20 – 14:30 | |
| 2PS-01-04 MULTICOMPONENT APHERESIS WITH THE MCS-PLUS | |
| P. Hoecker, G.L. Leitner, A.W. Wagner (Univ. Institute for Bloodgroup Serology, Vienna, Austria) | |
| 14:30 – 14:40 | |
| 2PS-01-05 BACTERIAL CONTAMINATION OF PLATELETS BY STREPTOCOCCUS MITIS: A CASE REPORT | |
| Y. Zhao, S. Hall, K. Love, P. Blatt (Christiana Care Health System, Newark, USA) | |
| 14:40 – 15:00 | |
| DISCUSSION TIME |
|
|
13:30 – 15:00
Auditorium B2
|
|
| PARALLEL SESSION 2: Risk Management in Blood Transfusion | |
| Chairs: A. Fletcher, N. Dhingra | |
| 13:30 – 13:50 | |
| 2PS-02-01 HEPATITIS C - THE LEGACY OF POST-TRANSFUSION INFECTION | |
| A. Fletcher (Growing Your Knowledge/Australian Red Cross Blood Services, Spit Junction, NSW, Australia) | |
| 13:50 – 14:10 | |
| 2PS-02-02 WHO QUALITY MANAGEMENT PROGRAMME | |
| N. Dhingra (WHO, Geneve, Switzerland) | |
| 14:10 – 14:20 | |
| 2PS-02-03 RHEOLOGICAL BEHAVIOUR OF STORED BLOOD WITH TIME IN A NIGERIAN BLOOD BANK | |
| I. Ajayi, O. Onaghise, C. Okojie (University of Benin, Benin City, Nigeria) | |
| 14:20 – 14:30 | |
| 2PS-02-04 EVALUATING THE SAFETY OF POTASSIUM LEVEL IN STORED BLOOD UNITS AFTER BEING IRRADIATED WITH GAMMA IRRADIATION UAE. EXPERIENCE | |
| M.Y. Raouf, A. Al Amiri (Ministry of Health, Sharjah, United Arab Emirates) | |
| 14:30 – 14:40 | |
| 2PS-02-05 DETECTION OR INACTIVATION OF BACTERIA CONTAMINATED PLATELET CONCENTRATES: COMPARISON OF BACTALERT® AND INTERCEPT® IN PREVENTING THE RELEASE OF PLT UNITS CONTAINING LOW NUMBERS OF VIABLE BACTERIA | |
| W. Nussbaumer, D. Schönitzer, C. Grabmer, B. Falkensammer, C. Lass-Flörl, M. Rheinschmidt, L. Corash, L. Lin (University Hospital Innsbruck, Innsbruck, Austria) | |
| 14:40 – 14:50 | |
| 2PS-02-06 EPIDEMIOLOGY OF TRANSFUSION RELATED ACUTE LUNG INJURY IN GIFIT, THE FRENCH HEMOVIGILANCE DATABASE. A STUDY OF THE FRENCH HEMOVIGILANCE NETWORK | |
| Ph. Renaudier, M.P. Vo Mai, J.M. Azanowsky, P. Breton, S. Cheze, A. Girard, L. Hauser, J.F. Legras, D. Rebibo, C. Waller, N. Ounnoughene (Lyon, France) | |
| 14:50 – 15:00 | |
| DISCUSSION TIME |
|
|
15:30 – 17:00
Auditorium A2
|
|
| PARALLEL SESSION 3: External Quality Assessment Scheme | |
| Chairs: E. Dax, J. McCluskey | |
| 15:30 – 15:50 | |
| 2PS-03-01 INFECTIOUS VIRUS MARKERS: HOW CAN ALL LABORATORIES ASSURE SAFE BLOOD? | |
| E. Dax (National Serology Reference Laboratory, Fitzroy, Australia) | |
| 15:50 – 16:10 | |
| 2PS-03-02 HLA | |
| J. McCluskey (University of Melbourne, Melbourne, Australia) | |
| 16:10 – 16:30 | |
| 2PS-03-03 OUR EXPERIENCE WITH MPHA FOR PLATELET SEROLOGY | |
| N.H. Tsuno, S. Morita, Y. Shibata, K. Takahashi (The University of Tokyo, Tokyo, Japan) | |
| 16:30 – 16:40 | |
| 2PS-03-04 A NOVEL METHOD OF EVALUATION THE PERFORMANCE OF AUTOMATED PIPETTOR WITH COLORIMETRY | |
| L. Liu (Shanghai Blood Center, Shanghai, China) | |
| 16:40 – 16:50 | |
| 2PS-03-05 THE FIRST INDIAN MULTICENTER EVALUATION OF INDIVIDUAL DONOR NUCLEIC ACID TESTING ( NAT) FOR SIMULTANEOUS DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS-1 ND HEPATITIS C AND B VIRUSES (HIV-I, HCV, HBV) | |
| R.N. Makroo, V. Raina, M. Kumar, S. Chakroborty, L. Jagannathan, M. Parihar-Malhotra, A. Ganguly, R.K. Chaudhary, N. Marwaha, N.K. Bhatia, A. Tiwari, S. Roy, A. Verma, A. Ganguly, B. Thakral (Indraprastha Apollo Hospital, New Delhi, India) | |
| 16:50 – 17:00 | |
| DISCUSSION TIME |
|
|
15:30 – 17:00
Auditorium B2
|
|
| PARALLEL SESSION 4: New Approaches in Controlling TTDs | |
| Chairs: P.M. Ness, P.F.W. Strengers | |
| 15:30 – 15:50 | |
| 2PS-04-01 PATHOGEN INACTIVATION OF CELLULAR COMPONENTS | |
| P.M. Ness (Johns Hopkins, Baltimore, USA) | |
| 15:50 – 16:10 | |
| 2PS-04-02 UV-C IRRADIATION, AN EFFICIENT TECHNOLOGY INCREASING | |
| BIOLOGICALS SAFETY | |
| P.F.W. Strengers, R. Laub, M. Giambattista, P. Caillet-Fauquet, M.L. Draps, Th. Branckaert, (Red Cross, Brussels, Belgium) | |
| 16:10 – 16:20 | |
| 2PS-04-03 MIRASOL® PRT INACTIVATES ORIENTIA TSUTSUGAMUSHI IN PLATELETS AND PLASMA PRODUCTS | |
| R.P. Goodrich, F.J. Rentas, R. Harman, C. Gomez, J. Salata, J. Childs, T. Silva, A. Kennedy, C. Meledandri, A.M. O'Sullivan, A. Richards, C. Chan, J. Jiang, H. Reddy, J. Li (Navigant Biotechnologies, Inc., Lakewood, USA) | |
| 16:20 – 16:30 | |
| 2PS-04-04 SOLVENT DETERGENT TREATED PLASMA: AN ALTERNATIVE TO CRYOSUPERNANT PLASMA IN THROMBOTIC THROMBOCYTOPENIC PURPURA | |
| G. Rock, S. Moeslichan Mz, B. Benny, W. Clark, P. Leblond, D. Sutton, M. Sternbach, G. Wells, Canadian Apheresis Group, Apheresis Nurses, K. Shumak (The Canadian Apheresis Group, Ottawa, Canada) | |
| 16:30 – 16:40 | |
| 2PS-04-05 INACTIVATION OF BLOOD-BORNE PATHOGENS IN APHERESIS PLASMA AND PLATELETS USING THE INTERCEPT BLOOD SYSTEM | |
| L. Sawyer, R. Mababangloob, A. Sampson-Johannes, P. Grellier, S. Charneau, K. Bernard, S. Lukehart, K. Murthy, B. Guillemain, V. Jauvin, R. Lane, J. Benach, K. Dupuis (Cerus Corporation, Concord, Ca, USA) | |
| 16:40 – 16:50 | |
| 2PS-04-06 LOOKBACK STUDY FOR TRANSFUSION-RELATED VIRAL INFECTION IN JAPAN | |
| M. Satake, H. Yugi, R. Taira, S. Hino, K. Tadokoro (Tokyo Red Cross Blood Center, Tokyo, Japan) | |
| 16:50 – 17:00 | |
| DISCUSSION TIME |
|
SATELLITE SYMPOSIUM |
|
|
17.00 – 18.30
Satellite Symposium organised by Pall LifeScience
Auditorium B2
|
|
| LOST IN TRANSFUSION : THE OCCULT DOWNSIDE OF BLOOD COMPONENT THERAPY |
|
| J. Isbister (Pall Australia, Lane Cave NSW, Australia) | |
|
|
|
|
|
08:30 – 10:00
Auditorium A2
|
|
| PLENARY LECTURES 3: Evidence Based Transfusion Medicine | |
| chairs: A. Farrugia, S. Jootar | |
| 08:30 – 09:15 | |
| 3PL-03-01 CLINICAL USE AND THE NEED FOR EVIDENCE-BASED TRANSFUSION MEDICINE | |
| P.F.W. Strengers (Sanquin, Amsterdam, The Netherlands) | |
| 09:15 – 10:00 | |
| 3PL-03-02 CLINICAL FEATURES OF TRANSFUSED PATIENTS IN SCOTLAND IN 2000 | |
| B. McClelland (Scottish National Blood Transfusion Service, Edinburgh,
Scotland) |
|
| 10:00 – 13:30 | |
| COFFEE BREAK |
|
PARALLEL SESSIONS |
|
|
10:30 – 12:00
Auditorium A2
|
|
| PARALLEL SESSION 5: Quality Management System | |
| Chairs: D.Teo, M.Y. Zhu | |
| 10:30 – 10:50 | |
| 3PS-05-01 A TOOL FOR BETTER TRANSFUSION PRACTICES | |
| D. Teo (Health Sciences Authority, Singapore, Singapore) | |
| 10:50 – 11:10 | |
| 3PS-05-02 OUTLINE OF QUALITY MANAGEMENT OF BTS’S IN CHINA | |
| Y.M. Zhu, K.Ch. Quian (Shanghai Blood Center, Shanghai, China) | |
| 11:10 – 11:20 | |
| 3PS-05-03 DONOR PROFILE ASSESSMENT, THE INITIATION OF SAFE BLOOD | |
| P. Sinha, R.K. Choudhary, P. Elhence, V. Ray (S.G.P.G.I.M.S, Lucknow, India) | |
| 11:20 – 11:30 | |
| 3PS-05-04 A COMPETENCY ASSESSMENT FOR TRANSFUSION MEDICINE USING A WEB BASED PROGRAM (ECAS-TMT) | |
| G. Rock, D. Van Klaveren, Transfusion Ontario Program, D. Neurath (The Canadian Apheresis Group, Ottawa, Canada) | |
| 11:30 – 11:40 | |
| 3PS-05-05 PROVUE-THE OTTAWA HOSPITAL EXPERIENCE | |
| G. Rock, D. Neurath, M. Tokessy, T. Mulder LaFrance (The Canadian Apheresis Group, Ottawa, Canada) | |
| 11:40 – 11:50 | |
| 3PS-05-06 ISBT 128 PROVIDES SUCH AN INTERNATIONAL STANDARD | |
| P. Ashford (ICCBBA, USA) | |
| 11:50 – 12:00 | |
| DISCUSSION TIME |
|
|
10:30 – 12:00
Auditorium B2
|
|
| PARALLEL SESSION 6: Stem Cell Transplant | |
| Chairs: P.J. Coghlan, J. McCluskey | |
| 10:30 – 10:50 | |
| 3PS-06-01 STEM CELL PLASTICITY: A VIEW FROM THE BRIDGE | |
| P.J. Coghlan (Australian Red Cross Blood Service, Melbourne, Australia) | |
| 10:50 – 11:10 | |
| 3PS-06-02 UNRELATED STEM CELL AND CORD BLOOD TRANSPLANT | |
| J. McCluskey (University of Melbourne, Melbourne, Australia) | |
| 11:10 – 11:20 | |
| 3PS-06-03 EXPANDING TCRVALPHA24 VBETA11(+) NKT CELLS IN HUMAN UMBILICAL CORD BLOOD AND ANALYSE THE SPECIFIC PHENOTYPE BY FLOW CYTOMETRIC ASSESSMENT | |
| Y. Liu (Transfusion Institute of Shanghai Blood, Shanghai, China) | |
| 11:20 – 11:30 | |
| 3PS-06-04 INDUCTION OF P210BCR-ABL PROTEIN-SPECIFIC CYTOTOXIC T-CELL RESPONSE WITH DENDRITIC CELLS FROM BUFFY COAT THROUGH RNA TRANSFECTION IN VITRO | |
| L. Gao, H.H. Fan, Y. Liu, X.X. Nie, Y.M. Yang, Y.C. Gong, K.-C. Qian, Y.M. Zhu (Shanghai Blood Center, Shanghai, China) | |
| 11:30 – 11:40 | |
| 3PS-06-05 RED BLOOD CELL EXCHANGE TO PREVENT SEVERE HEMOLYSIS AFTER MINOR ABO IMCOMPATIBLE PERIPHERAL BLOOD STEM CELL TRANSPLANTATION | |
| P. Hoecker, N. Worel, P.K. Kalhs (Univ. Institute for Bloodgroup Serology, Vienna, Austria) | |
| 11:40 – 12:00 | |
| DISCUSSION TIME |
|
| 12:00 – 13:30 | |
| LUNCH BREAK, VISIT TO THE EXHIBITION AND POSTERS |
|
SATELLITE SYMPOSIUM |
|
|
12.00 – 13.30
Satellite Symposium organised by Abbott
Auditorium A2
|
|
| EXPERIENCE WITH THE ABBOTT ARCHITECT IN BLOOD BANK SETTING | |
| Chr. Stebler (Blood Bank Basel, Basel, Switzerland) | |
| CURRENT TRENDS IN HBV SCREENING | |
| S. Stramer (American Red Cross, USA) | |
| SENSITIVITY OF FOUR NEW COMMERCIAL HBSAG ASSAYS TO DETECT MUTANT FORMS OF HEPATITIS B SURFACE ANTIGEN | |
| Dr. Ly (Laboratorie LCL, France) | |
|
|
|
12.00 – 13.30
Satellite Symposium organised by Roche Auditorium B2
|
|
| NAT & Blood Screening-Past, Present and Future | |
|
|
|
13:30 – 15:00
Auditorium A2
|
|
| PARALLEL SESSION 7: Practical Approach to TTI Testing | |
| Chairs: S. Wendel, S. Louisirirotchanakul | |
| 13:30 – 13:50 | |
| 3PS-07-01 PITFALL OF SEROLOGY IN HIV AND HEPATITIS VIRUSES | |
| S. Louisirirotchanakul (Facutly of Medicine Mahidol University, Bangkok, Thailand) | |
| 13:50 – 14:10 | |
| 3PS-07-02 MALARIA | |
| K. Kwon (Korean Red Cross/ Blood Transf Res Inst, Seoul, South-Korea) | |
| 14:10 – 14:30 | |
| 3PS-07-03 PRACTICAL APPROACH TO TTI TESTING SYPHILIS | |
| S. Wendel (Hospital Sirio-Libanês Blood Bank, Sao Paulo, Brazil) | |
| 14:30 – 14:40 | |
| 3PS-07-04 PROBLEMS OF TRANSFUSION TRANSMITTED INFECTION AMONG BLOOD DONORS IN YANGON CHILDREN’S HOSPITAL | |
| H. Htay Htay Tin (Yangon Children’s Hospital, Yangon, Myanmar (Burma)) | |
| 14:40 – 14:50 | |
| 3PS-07-05 ELEVATED ALT IN CHINESE BLOOD DONORS: PREDICTOR OF HCV NAT YIELD CASES OR CAUSE OF UNNECESSARY DONOR DEFERRAL? | |
| F.R. Ren, F.R. Ren, J.X. Wang, G.X. Wen, D. Anderson, G.J. Gao, L.X Yan, X.H. Bai, C.F. Jiang, Q.S. Lv, Z.Y. Liu, H. Shan (Beijing Red Cross Blood Center, Beijing, China) | |
| 14:50 – 15:00 | |
| DISCUSSION TIME |
|
|
13:30 – 15:00
Auditorium B2
|
|
| PARALLEL SESSION 8: Bloodless Medicine | |
| Chairs: P.M. Ness, R. Winslow | |
| 13:30 – 13:50 | |
| 3PS-08-01 THE RED CELL TRANSFUSION TRIGGER | |
| P.M. Ness (Johns Hopkins, Baltimore, USA) | |
| 13:50 – 14:10 | |
| 3PS-08-02 MP4 (HEMOSPAN®): A NEW HAEMOGLOBIN-BASED ALTERNATIVE TO RED CELL TRANSFUSION | |
| R. Winslow (Sangart, Inc, San Diego, California, USA) | |
| 14:10 – 14:20 | |
| 3PS-08-03 OVERVIEW OF NUCLEIC ACID TESTING (NAT) ON BLOOD DONATIONS IN SINGAPORE | |
| D. Teo, L. Wong, S. Lam (Health Sciences Authority, Singapore, Singapore) | |
| 14:20 – 14:30 | |
| 3PS-08-04 MONOCLONAL IGG SPECIFIC FOR THE CD44 ANTIGEN AMELIORATES MURINE ITP BY A MECHANISM DEPENDENT UPON THE EXPRESSION OF THE INHIBITORY FC[GAMMA]RIIB: A POTENTIAL ALTERNATIVE TO IVIG | |
| A.H. Lazarus, S. Song, A.R. Crow, V. Siragam (Canadian Blood Services, Toronto, Canada) | |
| 14:30 – 14:40 | |
| 3PS-08-05 OPTIMISING BLOOD USE: A STUDY EXPLORING POSSIBILITIES OF RATIONAL BLOOD USE IN A TERTIARY HOSPITAL OF A LOW INCOME COUNTRY | |
| K. Chaudhary (Dr.Ram Manohar Lohia Hospital, New Delhi, India) | |
| 14:40 – 14:50 | |
| 3PS-08-06 MURINE MONOCLONAL ANTIBODY TO H ANTIGEN | |
| S. Iyer, K. Vasantha, R. Pujari, A. Jadhav, D. Mohanty, K. Ghosh (Institute of Immunohaematology, Mumbai, India) | |
| 14:50 – 15:00 | |
| DISCUSSION TIME |
|
| 15:30 – 16:00 | |
| TEA BREAK |
|
|
15:30 – 17:00
Auditorium A2
|
|
| PARALLEL SESSION 9: The Art of Donor Recruitment | |
| Chairs: N. Mikkelsen, D. Teo | |
| 15:30 – 15:50 | |
| 3PS-09-01 DONOR CARE | |
| N. Mikkelsen (IFBDO/FIODS, Frederiksberg, Denmark) | |
| 15:50 – 16:10 | |
| 3PS-09-02 DONOR COUNSELING | |
| D. Teo (Health Sciences Authority, Singapore, Singapore) | |
| 16:10 – 16:20 | |
| 3PS-09-03 A PILOT STUDY ON DONOR EDUCATION IN REDUCING POST-DONATION VASOVAGAL REACTION | |
| C.K. Lin, C.K. Lee, C.K.O. Fung, V. Wong, J. Hong, C.K. Lee (Hong Kong RC Blood Transfusion Service, Hong Kong, Hongkong, China) | |
| 16:20 – 16:30 | |
| 3PS-09-04 VOLUNTARY BLOOD DONATION IN SRI LANKA | |
| S. Liyanage (National Blood Transfusion Service, Colombo, Sri Lanka) | |
| 16:30 – 16:40 | |
| 3PS-09-05 WOMEN BLOOD DONORS: WHY ARE THEY MORE PASSIVE THAN ACTIVE DONORS | |
| I. Petrovic, P. Kovacevic, S. Gruden, J. Pesic (University of Belgrade, Psychology Dep., Beograd, Serbia and Montenegro) | |
| 16:40 – 17:00 | |
| DISCUSSION TIME |
|
|
15:30 – 17:00
Auditorium B2
|
|
| PARALLEL SESSION 10: Blood Transfusion Immunology | |
| Chairs: T. Juji, J. McCarthy | |
| 15:30 – 15:50 | |
| 3PS-10-01 PLATELET REFRACTORINESS | |
| L.J. McCarthy, Indiana University School of Medicine, Inidianapolis, USA | |
| 15:50 – 16:10 | |
| 3PS-10-02 IMMUNOLOGICAL ADVERSE TRANSFUSION REACTIONS | |
| T. Juji (Japanese Red Cross, Tokyo, Japan) | |
| 16:10 – 16:20 | |
| 3PS-10-03 PREVENTION OF GVHD DEVELOPMENT IN MICE USING THE MIRASOL® PRT PROCESS | |
| R.P. Goodrich, L.D. Fast, G. DiLeone, J. Li (Navigant Biotechnologies, Inc., Lakewood, USA) | |
| 16:20 – 16:30 | |
| 3PS-10-04 UTILITY OF HAEMOGLOBIN COLOUR SCALE FOR HAEMOGLOBIN ESTIMATION OF BLOOD DONORS | |
| R. Sawant, Z. Bharucha, S. Rajadhyajsha, D. Das (Tata Memorial Centre - ACTREC, Navi Mumbai, India) | |
| 16:30 – 16:40 | |
| 3PS-10-05 NON-INVASIVE HB DETERMINATION IN A BLOOD DONOR SETTING | |
| P.V. Holland, O. Amir, A. Weinstein, O. Herzenstein, D. Dvir, E. Monashkin, E. Shinar (Delta Blood Bank, Elk Grove, Ca, USA) | |
| 16:40 – 16:50 | |
| 3PS-10-06 A BRIEF HISTORICAL TRANSFUSION TIMELINE | |
| J. McCarthy, S. Smith (Indiana University School of Medicine, Inidianapolis, USA) | |
| 16:50 – 17:00 | |
| DISCUSSION TIME |
|
|
|
|
|
|
08:30 - 10:00
Auditorium A2
|
|
| PARALLEL SESSION 11: Technology and Blood Transfusion | |
| Chairs: A. Farrugia, J.P. Allain | |
| 08:30 – 08:50 | |
| 4PS-11-01 IS BLOOD SAFETY AFFORDABLE? | |
| A. Farrugia (Therapeutic Goods Administration, Woden, Australia) | |
| 08:50 – 09:10 | |
| 4PS-11-02 NEW TESTING TECHNIQUES | |
| J.P. Allain (University of Cambridge, Cambridge, United Kingdom) | |
| 09:10 – 09:20 | |
| 4PS-11-03 REDUCING THE RISK OF TRANSFUSION TRANSMITTED HEPATITIS B IN NEW ZEALAND | |
| P. Flanagan, G. Charlewood, S. Horder, M. Dravitsky, H. Hollis (New Zealand Blood Service, Auckland, New Zealand) | |
| 09:20 – 09:30 | |
| 4PS-11-04 FIRST YIELD FOR HIV-1 NAT IN THE AUSTRALIAN BLOOD DONOR POPULATION – A REPEAT DONOR WITH ACUTE HIV-1 INFECTION | |
| A.R. Davis, S.L. Ismay, C. Kelso, L.R. Whybin, P.H. Cunningham, A.J. Keller (Australian Red Cross Blood Service, Sydney NSW, Australia) | |
| 09:30 – 09:40 | |
| 4PS-11-05 NUCLEIC ACID TESTING OF FIRST TIME INDONESIAN BLOOD DONORS | |
| Y. Soedarmono, M.F. Suyati, L.B. Purwati, F. Arfat (Indonesian Red Cross, Jakarta, Indonesia) | |
| 09:40 – 10:00 | |
| DISCUSSION TIME |
|
|
08:30 – 10:00
Auditorium B2
|
|
| PARALLEL SESSION 12: Disaster Management | |
| Chairs: J. Blietz, T. Makishima | |
| 08:30 – 08:50 | |
| 4PS-12-01 MAN MADE TERRORISM | |
| J. Blietz, B. Fitzgerald (National Blood Exchange, Bethesda, USA) | |
| 08:50 – 09:10 | |
| 4PS-12-02 NATURE-MADE: EARTHQUAKE, TSUNAMI | |
| T. Makishima (Japanese Red Cross Medical Center, Tokyo, Japan) | |
| 09:10 – 09:20 | |
| 4PS-12-03 NOVEL B(A)640 AND B(A)641 ALLELES DETECTED IN CHINESE INDIVIDUALS | |
| Z.H. Guo, D. Xiang, Z. Zhu, X. Liu (Shanghai Blood Center, Shanghai, China) | |
| 09:20 – 09:30 | |
| 4PS-12-04 SEQUENCING ANALYSIS OF RHESUS BOXES GENE AND ZYGOSITY DETERMINATION OF THE RHD GENE IN RHD NEGATIVE CHINESE HAN POPULATION | |
| Q. Xu, J. Ma (Shandong Blood Center, Jinan, China) | |
| 09:30 – 09:40 | |
| 4PS-12-05 DETECTION OF MILTENBERGER VARIANTS BY PHENOTYPING AND REAL-TIME POLYMERASE CHAIN REACTION IN A MULTI-ETHNIC POPULATION | |
| V.S. Nadarajan, H. Shanmugan (University Malaya, Kuala Lumpur, Malaysia) | |
| 09:40 – 10:00 | |
| DISCUSSION TIME |
|
| 10:00 – 10:30 | |
| COFFEE BREAK |
|
|
10:30 – 12:00
Auditorium A2
|
|
| PARALLEL SESSION 13: Risk Management of Donor | |
| Chairs: P.J. Coghlan, I. Nuchprayoon | |
| 10:30 – 10:50 | |
| 4PS-13-01 SOCIO-MEDICAL SELECTION OF DONORS | |
| P.J. Coghlan (Australian Red Cross Blood Service, Melbourne, Australia) | |
| 10:50 – 11:10 | |
| 4PS-13-02 RISK MANAGEMENT OF DONORS: ANEMIA AND IRON DEFICIENCY | |
| I. Nuchprayoon (Chulalongkorn University, Bangkok, Thailand) | |
| 11:10 – 11:20 | |
| 4PS-13-03 TO STUDY THE STORAGE LESIONS AND EFFECT OF GAMMA IRRADIATION ON BLOOD FROM G6PD DEFICIENT BLOOD DONORS | |
| P. Agarwal, N. Choudhury, S. Agarwal, R. Chaudhary, V.L. Ray (Sanjay Gandhi Post Graduate Institute, Lucknow, India) | |
| 11:20 – 11:30 | |
| 4PS-13-04 REJECTION RATE OF VOLUNTEERS AND THE PREVALENCE OF TRANSFUSION-TRANSMITTED DISEASES AMONG BLOOD DONORS OF DIFFERENT SOCIAL GROUPS IN TEHRAN PROVINCE | |
| M. Ghafouri, A. Zorch (Iranian Blood Transfusion Organization, Tehran, Iran) | |
| 11:30 – 11:40 | |
| 4PS-13-05 THE APPLICATION OF FLOW CYTOMETER IN DETERMINATION OF FETAL RED CELLS IN PREGNANT WOMEN’S BLOOD | |
| X.-X. Nie, D. Xiang, K. Wu, F. Gao (Shanghai Blood Center, Shanghai, China) | |
| 11:40 – 12:00 | |
| DISCUSSION TIME |
|
|
10:30 – 12:00
Auditorium B2
|
|
| PARALLEL SESSION 14: Component Support in Special Clinical Setting | |
| Chairs: P. Isarangkura, V. Suvatte | |
| 10:30 – 10:50 | |
| 4PS-14-01 COMPONENT SUPPORT IN SPECIAL CLINICAL SETTING, THALASSEMIA HEMOGLOBINOPATHIES | |
| V.S. Tanphaichitr, V. Suvatte (Siriraj Hospital Mahidol University, Bangkok, Thailand) | |
| 10:50 – 11:10 | |
| 4PS-14-02 COMPONENT SUPPORT IN SPECIAL CLINICAL SETTING - HEMOPHILIA | |
| P. Isarangkura (Ramathibodi Hospital, Bangkok, Thailand) | |
| 11:10 – 11:20 | |
| 4PS-14-03 IN VITRO PARAMETERS OF AUTOMATED WASHED RED BLOOD CELLS SEPARATED BY MEANS OF APHERESIS | |
| C. Grabmer, M. Popovsky, E. Amann, D. Schönitzer, S. Falaize, H. Hanske, E. Pages, W. Nussbaumer (University Hospital Innsbruck, Innsbruck, Austria) | |
| 11:20 – 11:30 | |
| 4PS-14-04 AUTOLOGOUS BLOOD UTILIZATION DURING RADICAL PROSTATECTOMY FOR PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE | |
| C. Zubair, R. Grant (Mayo Clinic, Jacksonville, USA) | |
| 11:30 – 11:40 | |
| 4PS-14-05 EFFECT OF TRANSFUSIONAL THERAPY ON PREECLAMPSIA IN SICKLE-CELL PREGNANT WOMEN : THE HOSPICES CIVILS DE LYON EXPERIENCE | |
| Ph. Renaudier, A. Perrozet, B. Durand, J. Troncy, F. Bouafia, C. Pondarre, A. Francina, R.C. Rudigoz, D. Raudrant, M. Berland, P. Gaucherand, C. Negrier (Lyon, France) | |
| 11 :40 – 12:00 | |
| DISCUSSION TIME |
|
| 12:00 – 13:30 | |
| LUNCH BREAK, VISIT TO THE EXHIBITION AND POSTERS | |
|
|
|
12.00 - 13.30
Satellite Symposium organised by BioOne
Auditorium A2
|
|
| Chair: S. Jootar | |
| RISK OF BLOOD TRANSFUSION | |
| A. Shimosaka (Chinese Academy of Medical Sciences, Heilongjiang Institute of Hematology, Xian Jiaotong University, The Fourth Military Medical University, Peking University School of Oncology China) | |
| DNA/RNA BINDING ACTIVITY OF PSORALEN COMPOUND | |
| J.E. Hearst (University of California, Department of Chemistry. USA) | |
| PATHOGEN INACTIVATION OF BLOOD PRODUCTS | |
| L. Lin (Cerus Corporation, Concord, USA) | |
|
|
| 13:30 – 15:00 Auditorium A2 | |
| PLENARY LECTURES 4: Re-engineering of BTS | |
| Chairs: C.K. Lin, T. Intragumtornchai | |
| 13:30 – 14:50 | |
| 4PL-04-01 HOW A TRANSFUSION SYSTEM CAN WORK | |
| F. Décary (Héma-Québec, Saint-Laurent, Canada) | |
| 14:15 – 15:00 | |
| 4PL-04-02 LESSONS FOR DANCING ON A MOVING CARPET | |
| J.R.S. Hetzel (Australian Red Cross Blood Service, Fitzroy, Victoria, Australia) | |
| 15:00 – 15:30 | |
| CLOSING CEREMONY |